Retrospective Study on the Safety of Daratumumab in Japanese Relapsed or Refractory Multiple Myeloma and Search for Risk Factors for Infusion Related Reaction | Zendy

AI Assistant Blog Pricing

Retrospective Study on the Safety of Daratumumab in Japanese Relapsed or Refractory Multiple Myeloma and Search for Risk Factors for Infusion Related Reaction

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.